Medline (MDLN) Signs First Prime Vendor Agreement with Mohawk Medbuy

Go back to Medline (MDLN) Signs First Prime Vendor Agreement with Mohawk Medbuy

Medline Inc (MDLN) PT Lowered to $45 at Barclays, 'Material input costs are the biggest swing factor in F26'

May 29, 2026 5:22 AM EDT

Barclays analyst Glen Santangelo lowered the price target on Medline Inc (NASDAQ: MDLN) to $45.00 (from $50.00) while maintaining a Overweight rating.

The analyst comments "Material input costs are the biggest swing factor in F26. Management quantified fuel as ~50bps of total COGS, which helps frame the impact of recent oil price volatility. We estimate that with oil prices up 50% YTD, this could represent an incremental ~25bp margin headwind from... More

Medline completes $2.68 billion secondary stock offering

May 28, 2026 4:30 PM EDT

Medline Inc. (NASDAQ: MDLN) completed a secondary offering of 72.6 million shares of Class A common stock at $37.00 per share, the company announced. The offering was conducted by selling stockholders affiliated with Blackstone Inc., Hellman & Friedman LLC and a subsidiary of the Abu Dhabi Investment Authority.

... More